NIH-funded research NIH-funded research

Understanding the differences in tuberculosis from lab models to human cases

Official title: Tuberculosis: Heterogeneity from Experimental Models to Human Disease

Funded at Keystone Symposia · NIH-11072739 · Data updated 2026-11-12

This study is all about a conference where scientists will come together to share ideas on how tuberculosis affects people differently and how treatments can be improved, with the hope of finding better ways to manage this serious disease.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionKeystone Symposia
NIH-funded
Lab location1 site (Silverthorne, United States)
Project startJanuary 23, 2025
Project endDecember 31, 2025
Funding year2025
Award (this year)$6,500
NIH project number1R13AI188928-01
Project IDNIH-11072739 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals affected by tuberculosis or those at high risk of infection.

Less likely to help

Patients who are not affected by tuberculosis or who do not have risk factors for the disease may not benefit from this research.

What this research studies

This research involves a conference focused on tuberculosis, which is a leading cause of infectious disease deaths worldwide. The event will gather scientists from around the world to discuss the various immune responses and biological factors that influence tuberculosis outcomes. By examining the differences in how tuberculosis affects individuals and how it responds to treatments, the conference aims to foster collaborations that could lead to improved understanding and management of the disease. Participants will explore both experimental models and human responses to infection and vaccination.

Why it matters

Potential benefit: If successful, this research could lead to better strategies for preventing and treating tuberculosis, ultimately saving lives.

How similar studies have gone: Previous conferences and research initiatives have successfully advanced the understanding of tuberculosis and its treatment, indicating that this approach has potential for impactful outcomes.

Where this research is happening

  • Keystone Symposia
    Silverthorne, United States
    Active

Researchers

  • Principal investigator: Sheppard, Terry L. — Keystone Symposia
  • Study coordinator: Sheppard, Terry L.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.